WO1995028934A3 - Utilisation d'inhibiteurs de mao-a dans la fabrication d'un medicament destine au traitement du syndrome de privation chez les fumeurs - Google Patents

Utilisation d'inhibiteurs de mao-a dans la fabrication d'un medicament destine au traitement du syndrome de privation chez les fumeurs Download PDF

Info

Publication number
WO1995028934A3
WO1995028934A3 PCT/EP1995/001492 EP9501492W WO9528934A3 WO 1995028934 A3 WO1995028934 A3 WO 1995028934A3 EP 9501492 W EP9501492 W EP 9501492W WO 9528934 A3 WO9528934 A3 WO 9528934A3
Authority
WO
WIPO (PCT)
Prior art keywords
smokers
inhibitors
manufacture
mao
medicament
Prior art date
Application number
PCT/EP1995/001492
Other languages
English (en)
Other versions
WO1995028934A2 (fr
Inventor
Roman Amrein
Ivan Berlin
Alain Puech
Original Assignee
Hoffmann La Roche
Assist Publ Hopitaux De Paris
Roman Amrein
Ivan Berlin
Alain Puech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche, Assist Publ Hopitaux De Paris, Roman Amrein, Ivan Berlin, Alain Puech filed Critical Hoffmann La Roche
Priority to AU24468/95A priority Critical patent/AU2446895A/en
Publication of WO1995028934A2 publication Critical patent/WO1995028934A2/fr
Publication of WO1995028934A3 publication Critical patent/WO1995028934A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne l'utilisation d'inhibiteurs de la monoamine oxydase-A dans la fabrication de médicaments destinés à lutter contre la consommation des produits du tabac et, en même temps, à limiter chez les fumeurs le syndrome de privation.
PCT/EP1995/001492 1994-04-22 1995-04-20 Utilisation d'inhibiteurs de mao-a dans la fabrication d'un medicament destine au traitement du syndrome de privation chez les fumeurs WO1995028934A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU24468/95A AU2446895A (en) 1994-04-22 1995-04-20 Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH125694 1994-04-22
CH1256/94-9 1994-04-22

Publications (2)

Publication Number Publication Date
WO1995028934A2 WO1995028934A2 (fr) 1995-11-02
WO1995028934A3 true WO1995028934A3 (fr) 1995-11-16

Family

ID=4206136

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1995/001492 WO1995028934A2 (fr) 1994-04-22 1995-04-20 Utilisation d'inhibiteurs de mao-a dans la fabrication d'un medicament destine au traitement du syndrome de privation chez les fumeurs

Country Status (2)

Country Link
AU (1) AU2446895A (fr)
WO (1) WO1995028934A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002521432A (ja) * 1998-07-31 2002-07-16 ベラ・ファーマシューティカルズ・インコーポレイテッド モクロベマイドを使用する、物質乱用の処置および予防のための方法および組成物
FR2788982B1 (fr) * 1999-02-02 2002-08-02 Synthelabo Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique
RU2366430C2 (ru) 2007-05-23 2009-09-10 Виктор Иванович Рощин Ингибиторы моноаминооксидазы, лекарственное средство и фармацевтическая композиция

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990004387A2 (fr) * 1988-10-26 1990-05-03 Massachusetts Institute Of Technology Composition de traitement de symptomes relatifs au manque de tabac

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990004387A2 (fr) * 1988-10-26 1990-05-03 Massachusetts Institute Of Technology Composition de traitement de symptomes relatifs au manque de tabac

Also Published As

Publication number Publication date
WO1995028934A2 (fr) 1995-11-02
AU2446895A (en) 1995-11-16

Similar Documents

Publication Publication Date Title
BR0016218A (pt) Artigo para fumar
AU1992592A (en) Treatment of drug withdrawal symptoms and drug craving with type b monoamine oxidase inhibitors
BR9801008A (pt) Formulação aerossol adequada para terapia, profilaxia ou contenção de infecções da mycobacterium tuberculosis de um pacientes sofrendo de tuberculose
EP0513702A3 (fr) Dérivés de la mélatonine utiles dans le traitement des troubles du sommeil et en pré-anesthésie
YU37602A (sh) Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns
EP0403129A3 (fr) Papier à cigarette multicouche pour la réduction de l'émission latérale de fumée
CA2321728A1 (fr) Epiallopregnanolone utilise pour traiter les troubles du systeme nerveux central
EP2087892A3 (fr) (S,S) Reboxetine pour traiter les troubles mentaux et de l'apprentissage liées à l'âge
MXPA03007712A (es) Sales farmaceuticas.
WO2002080708A3 (fr) Necessaire de fumeurs
NO954996L (no) Anvendelse av nona- og dekapeptider for fremstilling av et legemiddel for behandling av AIDS
YU34199A (sh) Primena inhibitora gastrointestinalne lipaze
EP0675120A3 (fr) Utilisation de l'ascorbyl-gamma-linolenate ou de l'ascorbyl-dihomo-gamma-linolenate pour le traitement de l'asthme, du cancer et des maladies cardiovasculaires ou inflammatoires
IS6394A (is) Lyfjablanda sem inniheldur solmítriptan
AU5489299A (en) Use of hydroxyrisperidone for the manufacture of a medicament for the treatment and prevention of psychoses, emesis and symptoms of withdrawal from alcohol and nicotine
IL130877A0 (en) Quinoxalines in a triple combination with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of aids
LT97135A (en) Use of melatonin in the manufacture of a medicament for treating patients suffering from drug addiction
WO2002053090A3 (fr) Association medicamenteuse d'une biguanine (metformine) et d'arginine
WO1995028934A3 (fr) Utilisation d'inhibiteurs de mao-a dans la fabrication d'un medicament destine au traitement du syndrome de privation chez les fumeurs
TR199801235T2 (xx) �nhibit�rlerin solunum stim�lasyonuna y�nelik ila� �retiminde kullan�m�.
PL321779A1 (en) Drug for use in therapy of obsessive-compulsive neurosis, sleep apnoea, secsual activity disorders, vomiting and kinetosis
GB9909135D0 (en) Cystic fibrosis medicaments
EP0357359A3 (fr) Articles à fumer
NO964915L (no) Transdermal avlevering av antiepileptiske legemidler
FI951683A (fi) Yhdisteiden, joilla on antiglukokortikoidiaktiivisuus, käytt¦ sellaisten lääkkeiden valmistamiseksi, jotka on tarkoitettu huumausaineiden tai huumausaineseosten spontaaniin tai laukaistuun vieroitusoireyhtymäänliittyvien oireiden estämiseen tai hoitoon, ja niitä sisältäviä

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AM AU BB BG BR BY CA CN CZ EE FI GE HU IS JP KG KP KR KZ LK LR LT LV MD MG MN MX NO NZ PL RO RU SG SI SK TJ TT UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase